Glucose Health Total Assets 2014-2019 | GLUC

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Glucose Health total assets from 2014 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Glucose Health total assets from 2014 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.

Related Stocks
Company Name	Market Cap
Abbott Laboratories (ABT)	$221.8B
Boston Scientific (BSX)	$151.4B
Stryker (SYK)	$149.1B
EssilorLuxottica (ESLOY)	$125.1B
Medtronic (MDT)	$117.2B
Lonza Group Ag (LZAGY)	$46B
Haleon (HLN)	$43.1B
GE HealthCare Technologies (GEHC)	$40.1B
ResMed (RMD)	$37.1B
Terumo (TRUMY)	$28.9B
Koninklijke Philips (PHG)	$25.6B
Zimmer Biomet Holdings (ZBH)	$22.1B
Insulet (PODD)	$19.4B
Baxter (BAX)	$16.7B
Smith & Nephew SNATS (SNN)	$11.1B
BellRing Brands (BRBR)	$10.1B
Sunny Optical Technology (SNPTF)	$10B
Bio-Rad Laboratories (BIO)	$10B
Demant (WILYY)	$8.7B
Lantheus Holdings (LNTH)	$6.4B
ICU Medical (ICUI)	$4.1B
Prestige Consumer Healthcare (PBH)	$3.9B
Envista Holdings (NVST)	$3.7B
Haemonetics (HAE)	$3.4B
Perrigo (PRGO)	$3.4B
GN Store Nord (GNNDY)	$3B
Shandong Weigao Medical Polymer (SHWGF)	$3B
QuidelOrtho (QDEL)	$2.9B
Neogen (NEOG)	$2.5B
LeMaitre Vascular (LMAT)	$2.2B